Amantadine penetration into cerebrospinal fluid of a child with influenza A encephalitis

Area of Science:

• Neurology
• Virology
• Infectious Diseases

Background:

• Influenza A encephalitis is a rare but severe neurological complication of influenza A virus infection.
• Amantadine is an antiviral medication sometimes used to treat influenza A, but its efficacy in treating influenza A encephalitis is not well-established.
• Limited data exist on cerebrospinal fluid (CSF) concentrations of amantadine and its impact on the pathogenesis of influenza A encephalitis.

Observation:

• A 2-year-old child diagnosed with influenza A encephalitis was treated with amantadine.
• The child's CSF amantadine concentration was measured and found to be potentially therapeutic.
• Despite amantadine treatment, the child experienced significant and lasting neurological impairment.

Findings:

• Amantadine treatment achieved potentially therapeutic concentrations in the cerebrospinal fluid of a child with influenza A encephalitis.
• The achievement of these concentrations did not prevent the development of severe neurological deficits.
• This case suggests that amantadine may not be effective in preventing neurological sequelae in severe influenza A encephalitis.

Implications:

• The findings challenge the established use of amantadine for influenza A encephalitis, particularly in severe cases.
• Further research is needed to understand the pathogenesis of influenza A encephalitis and to identify more effective therapeutic strategies.
• This case underscores the critical need for improved treatments to mitigate the severe neurological consequences of influenza virus infections affecting the central nervous system.